72 results found.
      
ConMed Posts 1Q17 Revenue -1.4% vs. 1Q16
ConMed posted 1Q17 arthroscopy/soft tissue repair revenue of US $103.8MM, -1.4% vs. 1Q16. 
ConMed Company Profile
We're redesigning Company Profiles. To get the most current news and articles about ConMed in the interim, please use...
Company Revenue 2016
For these publicly-traded orthopaedic device companies, Exhibits 1 and 2 present 2016 orthopaedic revenue and growth. Exhibit 1 includes links to company's full-year revenue reporting, as well. ...
Top 5 Orthopaedic Players Post Revenue Growth
Combined, the top five largest players in orthopaedics posted 2016 revenue of US $28.6BB, up $671.7MM or +2.4% vs. ...
ConMed Reports 2016 Revenue
ConMed posted 2016 arthroscopy/soft tissue repair revenue of US $370.5MM, -4.7% vs. 2015, with 4Q16 revenue of $98.0MM, -5.9% vs. 4Q1...
Company Revenue 3Q16: A Final Look
By Julie A. Vetalice As we wrap up orthopaedic revenue for the latest reporting period, we observe that Stryker and Zimmer Biomet lead the largest orthopaedic companies in 3Q16 growth:
ConMed Reports 3Q16 Orthopaedic Revenue
ConMed posted 3Q16 arthroscopy/soft tissue repair revenue of US $86.3MM, -3.5% worldwide vs. 3Q15. (U.S. and ex-U.S. also -3.5%) 
Company Revenue Update, 1H16
By Julie A. Vetalice We complete our coverage of 1H16 revenue in this issue. Stryker and Smith & Nephew lead the top five in growth, with 1H16 performance in the low-single-digits compared to 1H15. DePuy Synthes and Zimmer Biomet reported
ConMed Reports 2Q16 Orthopaedic Revenue
ConMed posted 2Q16 arthroscopy/soft tissue revenue of US $92.7MM, -4.2% vs. 2Q15. (U.S. -5.1%, ex-U.S. -3.6%
ConMed Posts 1Q16 Revenue
ConMed posted 1Q16 arthroscopy/soft tissue revenue of US $93.4MM, -5.2% vs. 1Q15. (U.S. +0.9%, ex-U.S. -9.0%) All grow...
CONMED Reports 2015 Revenue
CONMED posted 2015 orthopaedic revenue of US $389MM, +0.7% from 2014. (Growth reflects constant currency.)
Company Revenue 2015: CONMED
Download the March issue of ORTHOKNOW for a graphical presentation of 2015 company performance. 2015: $389.0MM, -3.4%/+0.7% CC...
CONMED Reports 3Q15 Revenue
CONMED reported 3Q15 orthopaedic revenue of US $89.4MM, -3.6% as reported and +1.4% in constant currency.
BARE BONES® - July 21, 2015
CONMED posted 2Q15 orthopaedic surgery product sales of US $96.8MM, -1% from 2Q14. (Growth reflects constant currency.) (
BARE BONES® - April 22, 2015
CONMED posted 1Q15 orthopaedic surgery product sales of US $98.6MM, -3.2% from 1Q14. (Growth reflects constant currency.) (
BARE BONES® - January 27, 2015
CONMED reported orthopaedic surgery product sales for 4Q14 of US $101.7MM, -3.9% vs. 4Q13, and 2014 of $402.8MM, -1.3% vs. 2013. (
2014 Revenue: CONMED
4Q14 revenue: $101.7MM, -4% (Sports Medicine -3%: U.S. -9%, ex-U.S. ~$61MM, -3%; Powered Instruments -2%: U.S. +1%) 2014 revenue: $402.8MM, -1% (Sports Medicine -1%: U.S. -8%, ex-U.S. ~$241.6MM, -1%; Powered Instruments +3%: U.S. +3%) On overall growth: ...
BARE BONES® - October 23, 2014
CONMED reported 3Q14 orthopaedic surgery product sales of US $92.8MM, -3.2% from 3Q13. Growth reflects constant currency. (CONM...
3Q14 Revenue: CONMED
$92.8MM, -3% U.S. SportsMed -9% due to reduced procedure-specific and resection sales, plus previous discontinuation of PRP products U.S. Powered Instruments +1% (Capital handpieces +6%, Single-use burrs and blades -3%) Edge ablation bipolar ra...
BARE BONES® - July 23, 2014
CONMED posted 2Q14 orthopaedic surgery product sales of US $102.4MM, +0.8% from 2Q13. (Growth reflects constant currency.) (
2Q14 Revenue: CONMED
$102.4MM, +0.8% Powered instrument handpieces +12% Shoulder repair devices +10% Sports tissue/biologic product sales decreased ~$1.3MM following contract supplier’s inability to supply platelet-rich plasma products for resale; will likely...
BARE BONES® - April 24, 2014
CONMED posted 1Q14 orthopaedic surgery product sales of US $105.9MM, +1.9% from 1Q13. (Growth reflects constant currency.) (
1Q14 Revenue: ConMed
$105.9MM, +2% Musculoskeletal Transplant Foundation (MTF)-related revenue -18% Powered Instruments +4% MTF revenue impacted by anticipated supplier inability to supply PRP devices for resale, may discontinue product Y-Knot Flex s...
Arthroscopy/Soft Tissue Repair Market Exceeds $4.5 Billion
The arthroscopy and soft tissue repair market topped an estimated $4.5 billion in 2013, an increase of seven percent from 2012. The market is expected to experience high single-digit growth in each of the next five years, remaining among the healthier segments in the orthopaedic industry.
BARE BONES® - February 13, 2014
CONMED reported 4Q13 orthopaedic surgery product sales of US $107.7MM, +2.2% from 4Q12, and 2013 sales of $410.2MM, +0.1% from 2012. (
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group